Search results
Avoiding tick bites is best defense against contracting Powassan virus (PV)
The Metrowest Daily News via Yahoo News· 1 year agoQ: I read that someone in Maine died of Powassan virus after getting it from a tick. Is this a new...
Dr. Hersh: This disease causes the bone marrow to make too many red blood cells
The Metrowest Daily News via Yahoo News· 9 months agoQ: My friend says his uncle is being treated for a disease where he has too much blood and he gets...
What Are Myeloproliferative Neoplasms?
Health via Yahoo News· 3 months agoMedically reviewed by Archana Sharma, DO Myeloproliferative neoplasms (MPNs) are a group of blood cancers that occur when your bone marrow makes too many...
What Is Axial Spondyloarthritis?
Health via Yahoo News· 4 months agosupersizer / Getty Images Medically reviewed by David Ozeri, MD Axial spondyloarthritis (axSpA) is a type of inflammatory arthritis that primarily...
What Is Myelofibrosis?
Health via Yahoo News· 5 months agoMyelofibrosis (MF) is a rare form of blood cancer that causes scarring (fibrosis) in the bone marrow—the spongy tissue inside your bones that produces...
What Is Bone Marrow Cancer?
Health via Yahoo News· 5 months agoBone marrow cancer is a group of cancers that develop in the blood cells of your bone marrow. The bone marrow is the spongey material inside the bones...
MorphoSys (MOR) Down 22% on Mixed Data From Myelofibrosis Study
Zacks via Yahoo Finance· 7 months agoThough data from the late study shows that treatment with MorphoSys' (MOR) combination therapy met...
Why Shares of Protagonist Therapeutics Rose This Week
Motley Fool· 1 year agoShares of Protagonist Therapeutics (NASDAQ: PTGX) rose by 23.3% for the week, as of Thursday...
Incyte (INCY) Stock Plummets 29.6% Year to Date: Here's Why
Zacks via Yahoo Finance· 8 months agoThe going has been tough for Incyte INCY in 2023. Pipeline setbacks and competition for lead drug...
Biotech Stock Roundup: VKTX, BMEA, ITCI Soar on Study Data, INCY Faces Setback
Zacks via Yahoo Finance· 1 year agoThe biotech sector has been in focus in the past week with key pipeline and regulatory updates....
